Company Sector
CAR-T Therapy
CAR-T Therapy includes companies engineering chimeric antigen receptor T cells to recognize and kill target cells. This category remains central to hematologic malignancies and is also watched closely for attempts to expand cell therapy into autoimmune disease and solid tumors.
Why watch CAR-T Therapy
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest CAR-T Therapy news
The latest feed items from companies currently grouped under CAR-T Therapy.
- 01
TCMDTactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients
Source: Tactile Systems Technology, Inc.
- 02
LCTXLineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
Source: Lineage Cell Therapeutics
- 03
MESOReceives FDA BLA Filing Number and Requests Modular Review
Source: Mesoblast
- 04
PSTVPlus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
Source: PLUS THERAPEUTICS, Inc.
- 05
MESOBecoming a substantial holder
Source: Mesoblast
- 06
MESOCeasing to be a substantial holder
Source: Mesoblast
- 07
- 08
- 09
MESOMesoblast Draws US$50M from Five-Year Non-Dilutive Facility
Source: Mesoblast
- 10
PSTVPlus Therapeutics to Provide Business Update Call on June 30, 2026
Source: PLUS THERAPEUTICS, Inc.
- 11
MESOBecoming a substantial holder
Source: Mesoblast
- 12
- 13
MESOCeasing to be a substantial holder
Source: Mesoblast
- 14
- 15
- 16
- 17
PSTVPlus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory
Source: PLUS THERAPEUTICS, Inc.
- 18
IOVAIovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia
Source: Iovance Biotherapeutics, Inc.
- 19
- 20
BCLIBrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine
Source: Brainstorm Cell Therapeutics Inc.
Companies in CAR-T Therapy
37 companies tagged with CAR-T Therapy.
Frequently Asked Questions
What does the CAR-T Therapy sector include?
CAR-T Therapy includes companies engineering chimeric antigen receptor T cells to recognize and kill target cells. This category remains central to hematologic malignancies and is also watched closely for attempts to expand cell therapy into autoimmune disease and solid tumors.
How many companies are currently tagged with CAR-T Therapy?
37 companies are currently grouped under CAR-T Therapy on BioPharmSignal.
Which companies are most visible in the CAR-T Therapy group right now?
ADAP, ALLO, AUTL, BCLI are among the companies currently shown on this sector page.
How can I watch news for CAR-T Therapy?
Use the Watch button on this page to subscribe to CAR-T Therapy headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for CAR-T Therapy?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in CAR-T Therapy.